Stanley Druckenmiller is a Wall Street legend whose trades are truly worth tracking due to how consistently he has been ...
Insmed has come up short in its attempt to expand its newly approved potential blockbuster Brinsupri into a new indication. | ...
Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...
As of Thursday, December 18, Insmed Incorporated’s INSM share price has dipped by 15.37%, which has investors questioning if ...
Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...
By designing a squaric acid amide that binds a new site on ATP synthase, researchers created PRP020, a potential therapy for ...
Japan's Shionogi has added to its antibiotics pipeline by partnering a preclinical-stage candidate from Swiss biotech BioVersys, which specialises in drugs that can counter antimicrobial resistance ...
Druckenmiller invests his personal and family's wealth through his fund, the Duquesne Family Office. Druckenmiller is high on biotech stocks, with his top three holdings at the end of the third ...
Gujarat Themis Biosyn Limited is an India-based company, which is principally engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The Company is focused on the business of ...
The final, formatted version of the article will be published soon. This study examined uncommon mastitis cases in a research barn incorporating recycled manure solids (RMS) as bedding. The cases ...